Anlon Healthcare Limited Stock Price

NSEI:AHCL Community·₹5.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

AHCL Share Price Performance

₹0

-91.73 (-100.00%)

₹0

-91.73 (-100.00%)

₹0

Thu, 5 Mar 26

Share Pricen/a

AHCL Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Solid track record with adequate balance sheet.

1 Risk

2 Rewards

View Full Analysis

Anlon Healthcare Limited Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 6.52
: 37.95%
: 20.38%
: 27.0%

View Full Analysis

About AHCL

Founded: 2013
Employees: 117
CEO: Punitkumar Rasadia
WebsiteView website: www.anlon.in

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.